BackSinopharm Group Ltd. Overview

Sinopharm Group Ltd. Inventory

Sinopharm Group Ltd.'s inventory is $67B.

Get informed when a big investor buys or sells

+ Follow
Inventory
$66.66B
↑ 1.74% YoYΔ $1.14B vs prior year quarter

Peer trimmed avg / median

Loading

Sinopharm Group Ltd. Inventory History

Loading

Sinopharm Group Ltd. vs. peers: Inventory Comparison

Loading

Sinopharm Group Ltd. Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Sinopharm Group Ltd. (SHTDY) FAQ

The latest inventory for SHTDY is $67B as of June 2026. That compares with $66B in the prior-year period — up 1.7% year over year. Investors often review this figure alongside Sinopharm Group Ltd.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, SHTDY's inventory moved from $66B to $67B — a 1.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Sinopharm Group Ltd.'s operating scale or balance-sheet position.

A inventory figure of $67B for SHTDY is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting SHTDY's inventory ($67B), review year-over-year change from $66B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.